Key result
Higher blood glucose variability was independently associated with increased lipid (β = 0.80) and decreased fibrous (β = -0.79) contents in coronary plaques among patients with acute coronary syndromes.
Why the study?
Does higher blood glucose variability correlate with coronary plaque instability in patients with acute coronary syndromes?
Observational (n=57)
No
Does higher blood glucose variability correlate with coronary plaque instability in patients with acute coronary syndromes?
Higher blood glucose variability, but not conventional glucose indicators, is independently associated with increased lipid and decreased fibrous contents in coronary plaques, suggesting it is a key factor in plaque vulnerability.
Glucose variability may mark vulnerable plaques in ACS; hypothesis-generating and requires prospective trials before clinical adoption.
BACKGROUND: Blood glucose variability is receiving considerable attention as a new risk factor for coronary artery disease. This study aimed to investigate the association between blood glucose variability and coronary plaque tissue characteristics. METHODS: In 57 patients with acute coronary syndrome, integrated backscatter intravascular ultrasound (IB-IVUS) and gray-scale IVUS were performed before balloon dilatation or stent implantation in the culprit vessels. Standard IVUS indices were evaluated for volume index (volume/length), and plaque components were measured by IB-IVUS for percent tissue volume. In addition to conventional glucose indicators, blood glucose variability in a stable state was determined by calculating the mean amplitude of glycemic excursions (MAGE) using a continuous glucose monitoring system. RESULTS: Higher MAGE values were significantly correlated with larger percent plaque volumes (r = 0.32, p = 0.015), and increased lipid (r = 0.44, p = 0.0006) and decreased fibrous (r = -0.45, p = 0.0005) plaque components. In contrast, HbA1c or fasting plasma glucose values were not significantly correlated with plaque volumes and percent plaque components. Homeostasis model assessment of insulin resistance values were positively correlated with vessel (r = 0.35, p = 0.007) and plaque (r = 0.27, p = 0.046) volumes, but not with percent plaque components. In multiple regression analysis, higher MAGE values were independently associated with increased lipid (β = 0.80, p = 0.0035) and decreased fibrous (β = -0.79, p = 0.0034) contents in coronary plaques. CONCLUSIONS: Among all glucose indicators studied, only higher blood glucose variability was an independent determinant of increased lipid and decreased fibrous contents with larger plaque burden, suggesting blood glucose variability as one of the important factors related to coronary plaque vulnerability.
No takes yet. Share an insight, caveat, or question.
Okada et al. (2015) conducted an observational in Acute coronary syndromes (n=57). Blood glucose variability (MAGE) vs. Conventional glucose indicators (HbA1c, FPG, HOMA-IR) was evaluated on Increased lipid content in coronary plaques (β = 0.80, p=0.0035). Higher blood glucose variability was independently associated with increased lipid (β = 0.80) and decreased fibrous (β = -0.79) contents in coronary plaques among patients with acute coronary syndromes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: